Ascend: Phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia

1. Ghia, P.
2. Pluta, A.
3. Wach, M.
4. Lysak, D.
5. Kozak, T.
6. Simkovic, M.
7. Kaplan, P.
8. Kraychok, I.
9. Illes, A.
10. de la Serna, J.
11. Dolan, S.
12. Campbell, P.
13. Musuraca, G.
14. Jacob, A.
15. Avery, E.
16. Lee, J.H.
17. Liang, W.
18. Patel, P.
19. Quah, C.
20. Jurczak, W.